These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8955363

  • 21. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
    Cao J, Drews M, Lee HM, Conner C, Bahou WF, Zucker S.
    Ann N Y Acad Sci; 1999 Jun 30; 878():710-2. PubMed ID: 10415815
    [No Abstract] [Full Text] [Related]

  • 22. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H, Essers L, Ulbrich N, Will H.
    Biol Chem; 1999 Sep 30; 380(9):1103-8. PubMed ID: 10543448
    [Abstract] [Full Text] [Related]

  • 23. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
    Shimada T, Nakamura H, Ohuchi E, Fujii Y, Murakami Y, Sato H, Seiki M, Okada Y.
    Eur J Biochem; 1999 Jun 30; 262(3):907-14. PubMed ID: 10411655
    [Abstract] [Full Text] [Related]

  • 24. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V, Will H, López-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G.
    J Biol Chem; 1996 Jul 19; 271(29):17124-31. PubMed ID: 8663255
    [Abstract] [Full Text] [Related]

  • 25. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y, Binner S, Nagase H.
    Biochem J; 1995 Jun 01; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [Abstract] [Full Text] [Related]

  • 26. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
    d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G.
    Eur J Biochem; 1997 Dec 15; 250(3):751-7. PubMed ID: 9461298
    [Abstract] [Full Text] [Related]

  • 27. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.
    Lafleur MA, Hollenberg MD, Atkinson SJ, Knäuper V, Murphy G, Edwards DR.
    Biochem J; 2001 Jul 01; 357(Pt 1):107-15. PubMed ID: 11415441
    [Abstract] [Full Text] [Related]

  • 28. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
    Matsumoto S, Katoh M, Saito S, Watanabe T, Masuho Y.
    Biochim Biophys Acta; 1997 Nov 01; 1354(2):159-70. PubMed ID: 9396633
    [Abstract] [Full Text] [Related]

  • 29. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.
    Benyon RC, Hovell CJ, Da Gaça M, Jones EH, Iredale JP, Arthur MJ.
    Hepatology; 1999 Oct 01; 30(4):977-86. PubMed ID: 10498650
    [Abstract] [Full Text] [Related]

  • 30. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T, Konishi Y.
    Carcinogenesis; 1999 Jul 01; 20(7):1323-9. PubMed ID: 10383907
    [Abstract] [Full Text] [Related]

  • 31. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R, Toth M, Peña D, Mobashery S.
    Cancer Res; 1995 Jun 15; 55(12):2548-55. PubMed ID: 7780967
    [Abstract] [Full Text] [Related]

  • 32. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K, Lohi J, Valtanen H, Keski-Oja J.
    Biochem J; 1998 Sep 01; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [Abstract] [Full Text] [Related]

  • 33. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
    Wang Y, Johnson AR, Ye QZ, Dyer RD.
    J Biol Chem; 1999 Nov 12; 274(46):33043-9. PubMed ID: 10551873
    [Abstract] [Full Text] [Related]

  • 34. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P.
    J Cell Biol; 1997 Apr 07; 137(1):67-77. PubMed ID: 9105037
    [Abstract] [Full Text] [Related]

  • 35. Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
    Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):126-30. PubMed ID: 11178970
    [Abstract] [Full Text] [Related]

  • 36. Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation.
    Zucker S, Hymowitz M, Conner CE, DiYanni EA, Cao J.
    Lab Invest; 2002 Dec 16; 82(12):1673-84. PubMed ID: 12480917
    [Abstract] [Full Text] [Related]

  • 37. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G, Cal S, Merlos-Suárez A, Ferrando AA, Alvarez S, Nakano A, Arribas J, López-Otín C.
    Cancer Res; 2000 Feb 15; 60(4):877-82. PubMed ID: 10706098
    [Abstract] [Full Text] [Related]

  • 38. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes.
    Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, Murphy G.
    J Biol Chem; 1995 Dec 22; 270(51):30479-85. PubMed ID: 8530478
    [Abstract] [Full Text] [Related]

  • 39. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H, Okada Y, Seiki M.
    Thromb Haemost; 1997 Jul 22; 78(1):497-500. PubMed ID: 9198203
    [Abstract] [Full Text] [Related]

  • 40. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
    Wang FQ, So J, Reierstad S, Fishman DA.
    Int J Cancer; 2005 Mar 10; 114(1):19-31. PubMed ID: 15523695
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.